The CBD market: COVID-19 impact, regulatory hurdles, trending NPD and alternatives

Related Articles

FormattedPicture

REGULATORY NEWS

The US Food and Drug Administration (FDA) has said no to three different citizen petitions requesting that cannabidiol (CBD) products be marketed as dietary supplements.... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Amid a significant growth spurt in the demand for weight management products, the segment demonstrates a progression from supplementation toward healthier lifestyle... Read More

FormattedPicture

REGULATORY NEWS

Amid a fast-growing market for dietary supplements containing cannabidiol (CBD) – the non-psychoactive compound found in cannabis – US regulators are... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

NutritionInsight looks back at the biggest industry developments of the year. From the US infant formula shortage to rising inflation, it was a year filled with... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Researchers from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King’s College London, have challenged the belief that cannabis with higher... Read More

trans